Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood.
In order to determine the sensitivity and reliability of antirotaviral fecal immunoglobulin A (IgA) as an indicator of rotavirus reinfection, the antibody responses to rotavirus of 44 infants with severe rotavirus gastroenteritis recruited on admission to a hospital were studied. Feces were collected daily during hospitalization and weekly thereafter, and sera were obtained every 4 months, for 6 to 32 months (median, 17 months). Antirotaviral IgG, IgA, and IgM were measured by enzyme immunoassay in all samples. Rotavirus antigen, rotavirus-neutralizing antibody, and total IgA were measured in feces. The results showed that use of an IgA index (ratio of specific IgA to total IgA) was unnecessary to identify copro-IgA conversion to rotavirus. The other markers of rotavirus infection tested showed a high level of predictive accuracy of coproconversion in rotavirus-neutralizing antibody. Copro-IgM, serum IgM, and virus in feces were insensitive measures of neutralizing antibody coproconversion. Seroconversion in IgG or IgA was detected in 46% of neutralizing coproconversions. The most sensitive marker, present in 92% of neutralizing coproconversions, was antirotaviral fecal IgA conversion. This correlation of fecal IgA with fecal neutralizing antibody suggests that coproconversions in IgA represent true elevations in antirotaviral IgA with neutralizing capacity. A coproconversion in IgA appears to indicate genuine rotavirus infection. Copro-IgA conversions in feces collected weekly are likely to be more sensitive markers of rotavirus reinfection than are seroconversion and virus detection combined in epidemiological studies of acute diarrhea in children and in rotavirus vaccine trials.
Coulson
B S
BS
Department of Gastroenterology, Royal Children's Hospital, Parkville, Victoria, Australia.
Grimwood
K
K
Masendycz
P J
PJ
Lund
J S
JS
Mermelstein
N
N
Bishop
R F
RF
Barnes
G L
GL
D000914:Antibodies, Viral / Q000276:immunology; D001315:Australia / Q000453:epidemiology; D015415:Biomarkers; D002675:Child, Preschool; D003967:Diarrhea / Q000150:complications / Q000453:epidemiology; D005243:Feces / Q000382:microbiology; D005453:Fluorescence; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis*; D007223:Infant; D007231:Infant, Newborn; D009500:Neutralization Tests; D012401:Rotavirus / Q000276:immunology*; D012400:Rotavirus Infections / Q000150:complications / Q000453:epidemiology*; D012680:Sensitivity and Specificity
D000914:Antibodies, Viral; D015415:Biomarkers; D007070:Immunoglobulin A